XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   12,497,770    
Beginning balance at Dec. 31, 2023 $ 280,315 $ 12 $ 4,425,104 $ (4,144,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 111   111  
Issuance of restricted common stock (in shares)   48,918    
Forfeiture of unvested restricted stock (in shares)   (6,446)    
Repurchases of common stock in open market (in shares)   (58,298)    
Repurchases of common stock in open market (999)   (999)  
Net income 468     468
Ending balance (in shares) at Mar. 31, 2024   12,481,944    
Ending balance at Mar. 31, 2024 $ 279,895 $ 12 4,424,216 (4,144,333)
Beginning balance (in shares) at Dec. 31, 2024 12,213,599 12,213,599    
Beginning balance at Dec. 31, 2024 $ 288,690 $ 12 4,419,991 (4,131,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 307   307  
Issuance of restricted common stock (in shares)   61,260    
Repurchases of common stock in open market (in shares)   (52,337)    
Repurchases of common stock in open market (867)   (867)  
Net income $ 4,539     4,539
Ending balance (in shares) at Mar. 31, 2025 12,222,522 12,222,522    
Ending balance at Mar. 31, 2025 $ 292,669 $ 12 $ 4,419,431 $ (4,126,774)